Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC472833 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9793 | High Similarity | NPC472832 |
0.9793 | High Similarity | NPC18308 |
0.9014 | High Similarity | NPC470266 |
0.8828 | High Similarity | NPC476522 |
0.8828 | High Similarity | NPC474986 |
0.8828 | High Similarity | NPC476013 |
0.8828 | High Similarity | NPC476520 |
0.8811 | High Similarity | NPC296437 |
0.8767 | High Similarity | NPC476521 |
0.8759 | High Similarity | NPC476433 |
0.8759 | High Similarity | NPC476528 |
0.8742 | High Similarity | NPC472834 |
0.8649 | High Similarity | NPC476408 |
0.7987 | Intermediate Similarity | NPC244700 |
0.7661 | Intermediate Similarity | NPC473585 |
0.7532 | Intermediate Similarity | NPC226184 |
0.7532 | Intermediate Similarity | NPC76544 |
0.7532 | Intermediate Similarity | NPC167285 |
0.75 | Intermediate Similarity | NPC217656 |
0.7486 | Intermediate Similarity | NPC265111 |
0.7342 | Intermediate Similarity | NPC89139 |
0.7283 | Intermediate Similarity | NPC164845 |
0.6646 | Remote Similarity | NPC57279 |
0.6549 | Remote Similarity | NPC87981 |
0.6549 | Remote Similarity | NPC174114 |
0.6541 | Remote Similarity | NPC477118 |
0.6505 | Remote Similarity | NPC477120 |
0.6464 | Remote Similarity | NPC317054 |
0.6341 | Remote Similarity | NPC33996 |
0.6327 | Remote Similarity | NPC276373 |
0.6312 | Remote Similarity | NPC246193 |
0.6304 | Remote Similarity | NPC477119 |
0.6303 | Remote Similarity | NPC129756 |
0.6301 | Remote Similarity | NPC476564 |
0.6294 | Remote Similarity | NPC5802 |
0.6286 | Remote Similarity | NPC239737 |
0.6263 | Remote Similarity | NPC157821 |
0.6243 | Remote Similarity | NPC290959 |
0.6211 | Remote Similarity | NPC104011 |
0.6168 | Remote Similarity | NPC317821 |
0.6139 | Remote Similarity | NPC116555 |
0.6138 | Remote Similarity | NPC24589 |
0.6135 | Remote Similarity | NPC267811 |
0.6127 | Remote Similarity | NPC150853 |
0.6126 | Remote Similarity | NPC313514 |
0.6108 | Remote Similarity | NPC313897 |
0.6102 | Remote Similarity | NPC93365 |
0.6093 | Remote Similarity | NPC4837 |
0.6093 | Remote Similarity | NPC312187 |
0.6081 | Remote Similarity | NPC18335 |
0.6071 | Remote Similarity | NPC209525 |
0.6071 | Remote Similarity | NPC161659 |
0.6042 | Remote Similarity | NPC282458 |
0.6042 | Remote Similarity | NPC78941 |
0.6 | Remote Similarity | NPC314152 |
0.6 | Remote Similarity | NPC229974 |
0.5988 | Remote Similarity | NPC189068 |
0.5962 | Remote Similarity | NPC68938 |
0.5954 | Remote Similarity | NPC309832 |
0.5954 | Remote Similarity | NPC219313 |
0.5938 | Remote Similarity | NPC476341 |
0.593 | Remote Similarity | NPC107374 |
0.593 | Remote Similarity | NPC21448 |
0.593 | Remote Similarity | NPC156461 |
0.5896 | Remote Similarity | NPC164665 |
0.5886 | Remote Similarity | NPC136349 |
0.5876 | Remote Similarity | NPC133782 |
0.5876 | Remote Similarity | NPC527 |
0.5876 | Remote Similarity | NPC144474 |
0.587 | Remote Similarity | NPC325906 |
0.5862 | Remote Similarity | NPC269827 |
0.5829 | Remote Similarity | NPC121222 |
0.582 | Remote Similarity | NPC189261 |
0.5819 | Remote Similarity | NPC161224 |
0.5815 | Remote Similarity | NPC324484 |
0.581 | Remote Similarity | NPC469975 |
0.5802 | Remote Similarity | NPC248007 |
0.5801 | Remote Similarity | NPC195140 |
0.5799 | Remote Similarity | NPC470323 |
0.5787 | Remote Similarity | NPC328479 |
0.5773 | Remote Similarity | NPC267078 |
0.5773 | Remote Similarity | NPC101676 |
0.5773 | Remote Similarity | NPC935 |
0.5754 | Remote Similarity | NPC212551 |
0.5754 | Remote Similarity | NPC302778 |
0.5754 | Remote Similarity | NPC473878 |
0.5747 | Remote Similarity | NPC474357 |
0.5742 | Remote Similarity | NPC477419 |
0.5742 | Remote Similarity | NPC477417 |
0.573 | Remote Similarity | NPC85689 |
0.573 | Remote Similarity | NPC185991 |
0.573 | Remote Similarity | NPC211025 |
0.5722 | Remote Similarity | NPC174802 |
0.5721 | Remote Similarity | NPC158055 |
0.5705 | Remote Similarity | NPC256849 |
0.5698 | Remote Similarity | NPC472816 |
0.5698 | Remote Similarity | NPC321814 |
0.5691 | Remote Similarity | NPC224076 |
0.5683 | Remote Similarity | NPC124276 |
0.5682 | Remote Similarity | NPC115595 |
0.5672 | Remote Similarity | NPC300139 |
0.5672 | Remote Similarity | NPC233431 |
0.5667 | Remote Similarity | NPC130586 |
0.5667 | Remote Similarity | NPC164952 |
0.566 | Remote Similarity | NPC189314 |
0.5659 | Remote Similarity | NPC226245 |
0.5658 | Remote Similarity | NPC476099 |
0.5644 | Remote Similarity | NPC109322 |
0.5635 | Remote Similarity | NPC217021 |
0.5635 | Remote Similarity | NPC470679 |
0.5633 | Remote Similarity | NPC477420 |
0.5633 | Remote Similarity | NPC477418 |
0.5632 | Remote Similarity | NPC8590 |
0.5628 | Remote Similarity | NPC250178 |
0.5619 | Remote Similarity | NPC191415 |
0.5617 | Remote Similarity | NPC139776 |
0.5611 | Remote Similarity | NPC207633 |
0.561 | Remote Similarity | NPC180493 |
0.561 | Remote Similarity | NPC469308 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC472833 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.7176 | Intermediate Similarity | NPD8120 | Approved |
0.7176 | Intermediate Similarity | NPD8121 | Phase 3 |
0.6845 | Remote Similarity | NPD7023 | Clinical (unspecified phase) |
0.6815 | Remote Similarity | NPD1058 | Discontinued |
0.6765 | Remote Similarity | NPD5969 | Clinical (unspecified phase) |
0.6684 | Remote Similarity | NPD3431 | Approved |
0.6684 | Remote Similarity | NPD3430 | Approved |
0.6646 | Remote Similarity | NPD4240 | Approved |
0.6615 | Remote Similarity | NPD7323 | Phase 2 |
0.6606 | Remote Similarity | NPD7158 | Phase 1 |
0.6595 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.6595 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.6595 | Remote Similarity | NPD5682 | Phase 3 |
0.6582 | Remote Similarity | NPD3905 | Phase 3 |
0.6552 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6546 | Remote Similarity | NPD4924 | Clinical (unspecified phase) |
0.6546 | Remote Similarity | NPD2879 | Approved |
0.6546 | Remote Similarity | NPD2881 | Approved |
0.6497 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.6497 | Remote Similarity | NPD1313 | Approved |
0.6456 | Remote Similarity | NPD9633 | Phase 3 |
0.6455 | Remote Similarity | NPD1658 | Discontinued |
0.645 | Remote Similarity | NPD4863 | Approved |
0.6422 | Remote Similarity | NPD6470 | Phase 3 |
0.642 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.6415 | Remote Similarity | NPD248 | Discontinued |
0.6412 | Remote Similarity | NPD3708 | Phase 2 |
0.641 | Remote Similarity | NPD6837 | Clinical (unspecified phase) |
0.6408 | Remote Similarity | NPD4854 | Phase 3 |
0.6393 | Remote Similarity | NPD3041 | Approved |
0.6382 | Remote Similarity | NPD6521 | Phase 3 |
0.6382 | Remote Similarity | NPD6520 | Phase 3 |
0.6382 | Remote Similarity | NPD2443 | Approved |
0.6382 | Remote Similarity | NPD2442 | Approved |
0.6373 | Remote Similarity | NPD2880 | Discontinued |
0.6369 | Remote Similarity | NPD9408 | Phase 3 |
0.6364 | Remote Similarity | NPD3696 | Approved |
0.6364 | Remote Similarity | NPD3695 | Approved |
0.6353 | Remote Similarity | NPD4709 | Approved |
0.635 | Remote Similarity | NPD2408 | Discontinued |
0.6347 | Remote Similarity | NPD3706 | Clinical (unspecified phase) |
0.6313 | Remote Similarity | NPD6229 | Phase 2 |
0.6313 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6313 | Remote Similarity | NPD1333 | Phase 3 |
0.6294 | Remote Similarity | NPD4183 | Phase 3 |
0.6294 | Remote Similarity | NPD4182 | Phase 3 |
0.6293 | Remote Similarity | NPD5643 | Phase 2 |
0.6263 | Remote Similarity | NPD5016 | Approved |
0.6256 | Remote Similarity | NPD1982 | Phase 1 |
0.625 | Remote Similarity | NPD3839 | Phase 2 |
0.625 | Remote Similarity | NPD3840 | Phase 2 |
0.6243 | Remote Similarity | NPD3378 | Clinical (unspecified phase) |
0.6237 | Remote Similarity | NPD3362 | Clinical (unspecified phase) |
0.6236 | Remote Similarity | NPD6074 | Clinical (unspecified phase) |
0.6231 | Remote Similarity | NPD4446 | Approved |
0.6226 | Remote Similarity | NPD1775 | Approved |
0.6226 | Remote Similarity | NPD1085 | Approved |
0.6223 | Remote Similarity | NPD2456 | Phase 2 |
0.6223 | Remote Similarity | NPD2457 | Phase 2 |
0.6218 | Remote Similarity | NPD3485 | Clinical (unspecified phase) |
0.6211 | Remote Similarity | NPD6418 | Phase 1 |
0.6202 | Remote Similarity | NPD5827 | Discontinued |
0.6201 | Remote Similarity | NPD1015 | Phase 2 |
0.6201 | Remote Similarity | NPD1016 | Phase 2 |
0.62 | Remote Similarity | NPD2008 | Discontinued |
0.6188 | Remote Similarity | NPD1215 | Discontinued |
0.6188 | Remote Similarity | NPD2647 | Phase 3 |
0.6176 | Remote Similarity | NPD2411 | Approved |
0.6175 | Remote Similarity | NPD1567 | Clinical (unspecified phase) |
0.6175 | Remote Similarity | NPD3347 | Clinical (unspecified phase) |
0.6169 | Remote Similarity | NPD1506 | Discontinued |
0.6158 | Remote Similarity | NPD2591 | Phase 2 |
0.615 | Remote Similarity | NPD5962 | Phase 2 |
0.615 | Remote Similarity | NPD5508 | Phase 1 |
0.615 | Remote Similarity | NPD7103 | Approved |
0.6133 | Remote Similarity | NPD5269 | Clinical (unspecified phase) |
0.6126 | Remote Similarity | NPD7138 | Phase 2 |
0.6124 | Remote Similarity | NPD5321 | Phase 3 |
0.6118 | Remote Similarity | NPD171 | Discontinued |
0.6115 | Remote Similarity | NPD2221 | Clinical (unspecified phase) |
0.6114 | Remote Similarity | NPD3107 | Discontinued |
0.6114 | Remote Similarity | NPD6849 | Phase 2 |
0.6114 | Remote Similarity | NPD6850 | Phase 2 |
0.6108 | Remote Similarity | NPD3860 | Discontinued |
0.6108 | Remote Similarity | NPD7297 | Phase 2 |
0.6102 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.6096 | Remote Similarity | NPD3432 | Approved |
0.6096 | Remote Similarity | NPD2930 | Clinical (unspecified phase) |
0.6095 | Remote Similarity | NPD2179 | Discontinued |
0.609 | Remote Similarity | NPD580 | Discontinued |
0.6082 | Remote Similarity | NPD6619 | Phase 3 |
0.6081 | Remote Similarity | NPD8836 | Approved |
0.6073 | Remote Similarity | NPD4940 | Approved |
0.6071 | Remote Similarity | NPD193 | Suspended |
0.6071 | Remote Similarity | NPD4765 | Approved |
0.6071 | Remote Similarity | NPD4764 | Approved |
0.6068 | Remote Similarity | NPD2363 | Discontinued |
0.605 | Remote Similarity | NPD2807 | Discontinued |
0.6048 | Remote Similarity | NPD6579 | Phase 2 |
0.6043 | Remote Similarity | NPD4155 | Approved |
0.6041 | Remote Similarity | NPD1952 | Discontinued |
0.604 | Remote Similarity | NPD2876 | Phase 3 |
0.604 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.604 | Remote Similarity | NPD6271 | Approved |
0.6033 | Remote Similarity | NPD2875 | Clinical (unspecified phase) |
0.6032 | Remote Similarity | NPD2523 | Phase 2 |
0.6032 | Remote Similarity | NPD2526 | Phase 2 |
0.6031 | Remote Similarity | NPD7434 | Approved |
0.602 | Remote Similarity | NPD5464 | Approved |
0.6019 | Remote Similarity | NPD7656 | Approved |
0.6019 | Remote Similarity | NPD7657 | Approved |
0.6011 | Remote Similarity | NPD2646 | Discontinued |
0.6011 | Remote Similarity | NPD3341 | Clinical (unspecified phase) |
0.601 | Remote Similarity | NPD2453 | Phase 2 |
0.601 | Remote Similarity | NPD2450 | Phase 2 |
0.601 | Remote Similarity | NPD2451 | Phase 2 |
0.601 | Remote Similarity | NPD2452 | Phase 2 |
0.6 | Remote Similarity | NPD185 | Approved |
0.6 | Remote Similarity | NPD5072 | Discontinued |
0.6 | Remote Similarity | NPD7722 | Suspended |
0.5991 | Remote Similarity | NPD7173 | Approved |
0.5991 | Remote Similarity | NPD7172 | Approved |
0.599 | Remote Similarity | NPD4902 | Discontinued |
0.5989 | Remote Similarity | NPD2524 | Discontinued |
0.5988 | Remote Similarity | NPD1730 | Discontinued |
0.598 | Remote Similarity | NPD4612 | Discontinued |
0.598 | Remote Similarity | NPD2824 | Phase 2 |
0.5979 | Remote Similarity | NPD4716 | Approved |
0.5978 | Remote Similarity | NPD2333 | Discontinued |
0.5972 | Remote Similarity | NPD6210 | Phase 3 |
0.5969 | Remote Similarity | NPD460 | Discontinued |
0.5968 | Remote Similarity | NPD1037 | Clinical (unspecified phase) |
0.5967 | Remote Similarity | NPD3083 | Approved |
0.5962 | Remote Similarity | NPD4395 | Phase 1 |
0.596 | Remote Similarity | NPD5446 | Phase 2 |
0.5956 | Remote Similarity | NPD2135 | Approved |
0.5956 | Remote Similarity | NPD7988 | Suspended |
0.5956 | Remote Similarity | NPD2136 | Approved |
0.5956 | Remote Similarity | NPD2134 | Approved |
0.5952 | Remote Similarity | NPD4541 | Clinical (unspecified phase) |
0.5952 | Remote Similarity | NPD799 | Phase 1 |
0.5951 | Remote Similarity | NPD2295 | Clinical (unspecified phase) |
0.5951 | Remote Similarity | NPD1600 | Suspended |
0.595 | Remote Similarity | NPD6816 | Phase 3 |
0.5949 | Remote Similarity | NPD3419 | Clinical (unspecified phase) |
0.5947 | Remote Similarity | NPD4744 | Clinical (unspecified phase) |
0.5942 | Remote Similarity | NPD7164 | Discontinued |
0.5941 | Remote Similarity | NPD2364 | Suspended |
0.5936 | Remote Similarity | NPD5666 | Phase 2 |
0.5933 | Remote Similarity | NPD2412 | Clinical (unspecified phase) |
0.593 | Remote Similarity | NPD249 | Approved |
0.593 | Remote Similarity | NPD6469 | Phase 3 |
0.593 | Remote Similarity | NPD166 | Approved |
0.593 | Remote Similarity | NPD6468 | Clinical (unspecified phase) |
0.593 | Remote Similarity | NPD250 | Approved |
0.5924 | Remote Similarity | NPD578 | Discontinued |
0.5924 | Remote Similarity | NPD6794 | Approved |
0.5918 | Remote Similarity | NPD5973 | Phase 2 |
0.5918 | Remote Similarity | NPD4615 | Phase 2 |
0.5918 | Remote Similarity | NPD5974 | Approved |
0.5913 | Remote Similarity | NPD5679 | Clinical (unspecified phase) |
0.5907 | Remote Similarity | NPD6721 | Phase 1 |
0.59 | Remote Similarity | NPD5854 | Approved |
0.5893 | Remote Similarity | NPD2602 | Clinical (unspecified phase) |
0.5891 | Remote Similarity | NPD6129 | Phase 2 |
0.5889 | Remote Similarity | NPD2927 | Phase 3 |
0.5886 | Remote Similarity | NPD548 | Clinical (unspecified phase) |
0.5882 | Remote Similarity | NPD5324 | Clinical (unspecified phase) |
0.588 | Remote Similarity | NPD7694 | Discontinued |
0.5876 | Remote Similarity | NPD2009 | Clinical (unspecified phase) |
0.5875 | Remote Similarity | NPD4262 | Discontinued |
0.5874 | Remote Similarity | NPD2819 | Clinical (unspecified phase) |
0.5873 | Remote Similarity | NPD7111 | Discontinued |
0.587 | Remote Similarity | NPD1777 | Approved |
0.587 | Remote Similarity | NPD1776 | Approved |
0.5868 | Remote Similarity | NPD4763 | Clinical (unspecified phase) |
0.5865 | Remote Similarity | NPD4352 | Phase 1 |
0.5865 | Remote Similarity | NPD2902 | Phase 2 |
0.5865 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.5864 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.5864 | Remote Similarity | NPD4649 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD4714 | Approved |
0.5862 | Remote Similarity | NPD4713 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD195 | Approved |
0.5862 | Remote Similarity | NPD186 | Discovery |
0.5862 | Remote Similarity | NPD34 | Approved |
0.5862 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD4715 | Clinical (unspecified phase) |
0.5854 | Remote Similarity | NPD7445 | Phase 1 |
0.5854 | Remote Similarity | NPD6328 | Clinical (unspecified phase) |
0.5853 | Remote Similarity | NPD1571 | Phase 2 |
0.5853 | Remote Similarity | NPD7887 | Approved |
0.5853 | Remote Similarity | NPD7888 | Approved |
0.5851 | Remote Similarity | NPD7006 | Approved |
0.5848 | Remote Similarity | NPD2253 | Discontinued |
0.5846 | Remote Similarity | NPD7504 | Discontinued |
0.5845 | Remote Similarity | NPD6192 | Phase 3 |
0.5842 | Remote Similarity | NPD5730 | Phase 2 |
0.5842 | Remote Similarity | NPD40 | Phase 2 |
0.5842 | Remote Similarity | NPD4142 | Discontinued |
PubChem CID   | |
ChEMBL   | CHEMBL3586407 |
ZINC   |
Molecular Weight:   | 436.31 |
ALogP:   | 1.1886 |
MLogP:   | 3.66 |
XLogP:   | 4.572 |
# Rotatable Bonds:   | 15 |
Polar Surface Area:   | 77.68 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 1 |
# Rings:   | 3 |
# Heavy Atoms:   | 32 |